Body Protecting Compound-157 , , -
Precursor-directed immune-mediated anemia Dogs and cats with precursor-directed immune-mediated anemia (PIMA, also called non-regenerative immune-mediated anemia) usually present with severe normocytic normochromic anemia (Hcts, 20% cells with bound IgG) in low numbers of dogs (5/17, 29%) and a similar number of precursors were expressing phosphatidylserine (20-80% of cells)
doi: 10.1046/j.1524-475X.1994.20406.x
Not intended for human consumption
Discovered in the early 1990s, it was isolated from human gastric (stomach) juice and shows remarkable stability even in the harsh gastric environment Preclinical Findings (Animal and Lab Studies) Tissue Healing & Regeneration BPC-157 has shown promising effects in animal models, accelerating healing in tissues such as skin, mucosa, muscle, tendon, ligament, bone, and even the cornea

Retatrutide Dosing Calculator 1 mg pull the syringe to 10 units Warning: Syringe volume is not sufficient for specified dosage Researchers commonly need to calculate injection volumes based on reconstitution concentration: Example: 20mg Vial Reconstituted in 2mL BAC Water Concentration: 10mg/mL (10,000mcg/mL) For a 1mg dose: draw 0.1mL (10 units on a 1mL insulin syringe) For a 4mg dose: draw 0.4mL (40 units) For a 8mg dose: draw 0.8mL (80 units) Example: 40mg Vial Reconstituted in 2mL BAC Water Concentration: 20mg/mL (20,000mcg/mL) For a 4mg dose: draw 0.2mL (20 units) For a 8mg dose: draw 0.4mL (40 units) For a 12mg dose: draw 0.6mL (60 units) Research Supplies Available in Canada Great Northern Peptides provides research-grade retatrutide for Canadian researchers: Retatrutide 20mg vials ideal for lower-dose research protocols Retatrutide 40mg vials suited for higher-dose protocols or longer study durations All retatrutide products browse the full selection All products include third-party certificates of analysis (COA) verifying purity and identity
